Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Spironolactone in the Treatment of Heart Failure [Phase 3]
A Phase 3 trial evaluating spironolactone for heart failure with mid-range or preserved ejection fraction has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT [Phase 2]
Phase 2 study evaluating mavacamten in participants with heart failure with preserved ejection fraction and elevated NT-proBNP (with or with…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: HEART Camp Connect: A Feasibility Study [NA]
The HEART Camp Connect feasibility trial in heart failure with preserved ejection fraction was terminated, and results were posted on 2025-0…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function
A completed study evaluates how cardiac diastolic function and coronary microvascular function relate to prognosis in ischemic heart disease…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Metformin for Pulmonary Hypertension HFpEF [Phase 2]
A Phase 2 clinical trial sponsored by the University of California, San Francisco is evaluating metformin for pulmonary hypertension in pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Effects of a Supervised Training Program on Functional Capacity in Patients With HFpEF and Chronotropic Incompetence [NA]
This clinical trial update reports the completion of a supervised training program study assessing its effects on functional capacity in pat…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation in Heart Failure [NA]
Completed clinical trial evaluating transcutaneous vagus nerve stimulation for heart failure, including preserved and mid-range ejection fra…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Qishenyiqi Dripping Pills for chronic heart failure with preserved ejection fraction has…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the myeloperoxidase inhibitor A_Zeneca in heart failure with preserved ejection fraction has completed, with re…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Developing Oral LT3 Therapy for Heart Failure - HFpEF [Phase 1, Phase 2]
Phase 1/2 trial evaluating oral liothyronine (LT3) for heart failure with preserved ejection fraction and low T3 syndrome has completed, wit…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Effectiveness of CRD-740 in Heart Failure [Phase 2]
Cardurion Pharmaceuticals reports the Phase 2 trial of CRD-740 in heart failure has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Peripheral Microvascular Blood Flow in ANOCA
A completed clinical trial evaluating peripheral microvascular blood flow in Angina with nonobstructive coronary arteries and heart failure …
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF
This clinical trial update reports on the characteristics and predictors of adverse outcomes in heart failure with preserved ejection fracti…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Acute Effects of Exogenous Ketone Ester Administration in Heart Failure [Phase 2]
Phase 2 trial evaluating the acute effects of an exogenous ketone ester in heart failure with preserved ejection fraction; results have been…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: NMES in HF Patients to Improve Functional Recovery Following Hospitalization [NA]
A completed clinical trial evaluating neuromuscular electrical stimulation (NMES) to aid functional recovery in patients with heart failure …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial [Phase 4]
A Phase 4 randomized trial of polydiuretic therapy for heart failure with preserved ejection fraction has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Novartis reports completion of a clinical trial evaluating heart failure therapy and patient outcomes in individuals with mildly reduced or …
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure With Preserved Ejection Fraction [NA]
A completed clinical trial evaluating Pogejiuxin Decoction in combination with conventional Western medicine for heart failure with preserve…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: MyoMobile Study: App-based Activity Coaching in Patients with Heart Failure and Preserved Ejection Fraction
The MyoMobile Study, an app-based activity coaching trial in patients with heart failure with preserved ejection fraction, has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction [Phase 4]
Phase 4 trial update evaluating empagliflozin for improving functional capacity in heart failure with preserved ejection fraction has comple…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Sleep Apnea in Heart Failure With Preserved Ejection Fraction
This completed clinical trial examined sleep apnea in patients with heart failure with preserved ejection fraction.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF [Phase 2]
Phase 2A double-blind, placebo-controlled dose-escalation study evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of H…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction [Phase 3]
Phase 3 trial comparing LCZ696 (sacubitril/valsartan) to valsartan on cognitive function in patients with chronic heart failure with preserv…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) [Phase 3]
Phase 3 trial PARAGLIDE-HF in heart failure with preserved ejection fraction patients after decompensation reports NT-proBNP changes, safety…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs [Phase 2]
Phase 2 trial shows regression of fibrosis and reversal of diastolic dysfunction in heart failure with preserved ejection fraction after tre…